Impact of PLA2G2A rs11573156 C > G Variant on Phospholipase Expression and Metastatic Behavior in Prostate Cancer
Author:
Bedir IpekORCID,
Ozturk Kaan,
Telci DilekORCID
Reference60 articles.
1. Phospholipases: an overview;Aloulou;Methods Mol. Biol.,2018
2. Mortality results from a randomized prostate-cancer screening trial;Andriole;N. Engl. J. Med.,2009
3. Artru, F., McPhail, M.J.W., Triantafyllou, E., Trovato, F.M., 2022. Lipids in liver failure syndromes: a focus on eicosanoids, specialized pro-resolving lipid mediators and lysophospholipids. Front Immunol. 10.3389/FIMMU.2022.867261.
4. Secretory phospholipase 2 (sPLA2) in carcinogenesis and tumor microenvironment;Bedir;Phospholipases Physiol. Pathol.: Volumes 1–7,2023
5. Genetics of prostate cancer and its utility in treatment and screening;Benafif;Adv. Genet.,2021